Shares of Medidata Solutions (MDSO) Drops From a Buy to Hold

MDSO stock a hold in latest weekly rating.

By Portfolio Grader

Currently, Medidata Solutions (NASDAQ:MDSO) has a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

MDSO is one of the 783 companies in the GICS Health Care sector and is a component of the 25 company Health Care Technology GICS industry group within this sector. The market value of MDSO is $4.4 billion which places it in the top 25% of its industry group Portfolio Grader's current ranking for MDSO puts it 11 among the 25 companies in this industry group, giving it an above-average position.

The Health Care sector is ranked number 8 among the 12 sectors in the Portfolio Grader universe putting it in the third quartile of all the GICS sectors. The Health Care Technology industry group is ranked 38 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.

MDSO has attained above-average scores in 4 of the 8 fundamental areas appraised by Portfolio Grader and average or below-average scores in 4 of the areas evaluated in the ranking of company stocks.

MDSO's operational scores are a source of strength with a ranking for sales growth, operating margin and earnings growth that are discernibly above average. Scores for visibility of earnings are mixed, with rankings for earnings revisions and earnings momentum that are worse than average, while the score for earnings surprises is better than average. MDSO's metrics for cash flow and return on equity are worse than its industry group average. Medidata Solutions' fundamental scores give MDSO a place in the top quartile of the industry group.

Portfolio Grader uses the Navellier Proprietary Quantitative Score to view MDSO's shares from the perspective of risk/reward. This exclusive scoring methodology assesses the relative value of the company's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Considering this risk/reward calculation, MDSO currently scores as average in its industry group compared to its peers.

Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.

Commentary provided by UpTick Data Technologies.

Article printed from InvestorPlace Media,

©2018 InvestorPlace Media, LLC